Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection

Kaloyannidis, P., Ayyad, A., Bahaliwah, Z., Blowi, B., Alanazi, W., Al Shammasi, Z., … Al Hashmi, H. (2021, August 1). Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection. Bone Marrow Transplantation. Springer Nature. https://doi.org/10.1038/s41409-021-01318-6